Skip to main content
Ronald Crystal, MD, Pulmonology, New York, NY, New York-Presbyterian Hospital

RonaldGCrystalMD

Pulmonology New York, NY

Pleural Disease

The Bruce Webster Professor of Internal Medicine. Professor of Medicine. Professor of Genetic Medicine. Attending Physician, NewYork-Presbyterian Hospital.

Overview of Dr. Crystal

Dr. Ronald Crystal is a pulmonologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 49 years. Dr. Crystal accepts several types of health insurance, listed below. He is one of 232 doctors at New York-Presbyterian Hospital and one of 232 doctors at New York-Presbyterian Hospital who specialize in Pulmonology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1973 - 1973
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1968 - 1970
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - Present
  • NY State Medical License
    NY State Medical License 1993 - 2026
  • FL State Medical License
    FL State Medical License 2017 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Elected Member The American Society for Clinical Investigation, 1978
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Articles Disease Characteristics and Progression in Patients with Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease: An Observational Cohort Study  
    Barry Kosofsky, Kaleb Yohay, Ronald G Crystal, ScienceDirect
  • Gene Therapy for C1 Esterase Inhibitor Deficiency in a Murine Model of Hereditary Angioedema  
    Ronald G Crystal, Stephen M Kaminsky, Allergy

Lectures

  • Biologic Therapeutics Seminar Series - Developing Viral-based Therapies Against Brain Tumors 
    Washington University School of Medicine, Saint Louis, Missouri - 4/25/2012
  • Biologic Therapeutic Seminar Series - Treatment of B Cell Malignancies & Mesothelioma with Recombinant Immunotoxins 
    Washington University School of Medicine, Saint Louis, Missouri - 3/21/2012
  • Biologic Therapeutics Seminar Series - In Vivo Gene Transfer for Genetic Disease: Progress & Challenges 
    Washington University School of Medicine, Saint Louis, Missouri - 1/25/2012

Press Mentions

  • XyloCor Makes Significant Progress in Gene Therapy for Cardiovascular Disease
    XyloCor Makes Significant Progress in Gene Therapy for Cardiovascular DiseaseJanuary 30th, 2023
  • A Promising Trial Targets a Genetic Risk for Alzheimer’s
    A Promising Trial Targets a Genetic Risk for Alzheimer’sDecember 2nd, 2022
  • WCM-Q Research Reveals Metabolic Processes Underpinning Type 2 Diabetes, Complications
    WCM-Q Research Reveals Metabolic Processes Underpinning Type 2 Diabetes, ComplicationsMay 19th, 2022
  • Join now to see all

Grant Support

  • COPD Metabolome, Smoking Oxidants And Aberrant Ciliated Cell FunctionNational Heart, Lung, And Blood Institute2012
  • Overlapping Airway Basal Cell Transcriptome Reprogramming In COPD And Lung CancerNational Heart, Lung, And Blood Institute2011–2012
  • Management Project - Gene Therapy For Metachromatic LeukodystrophyNational Institute Of Neurological Disorders And Stroke2011
  • Gene Therapy For Metachromatic LeukodystrophyNational Institute Of Neurological Disorders And Stroke2011
  • Gene Therapy For Batten Disease Using Aavrh.10 Expressing Human CLN2 CDNANational Institute Of Neurological Disorders And Stroke2010–2011
  • Adenovirus-Based Nanoparticle VaccinesNational Institute On Drug Abuse2009–2011
  • Assessment Of Neurological Deterioration In Subjects With LinclNational Institute Of Neurological Disorders And Stroke2009–2011
  • Pulmonary Genetic Medicine Training ProgramNational Heart, Lung, And Blood Institute2009–2011
  • Dysregulation Of Ciliogenesis In The Ariway Epithelium In COPDNational Heart, Lung, And Blood Institute2007–2011
  • Disarray Of Injury/Regeneration Homeostasis In Smoking-Induced COPDNational Heart, Lung, And Blood Institute2007–2011
  • AdministrationNational Heart, Lung, And Blood Institute2007–2011
  • Adenovirus-Based Anti-Cocaine VaccineNational Institute On Drug Abuse2009–2010
  • Gene Therapy For Batten DiseaseNational Institute Of Neurological Disorders And Stroke2005–2009
  • Vaccine PlatformsNational Institute Of Allergy And Infectious Diseases2008
  • Gene Therapy For Cystic FibrosisNational Heart, Lung, And Blood Institute1993–2008
  • Genotype-Phenotype Of LinclNational Center For Research Resources2005–2007
  • Gene Transfer Vector Human CLN2 CDNA Brain Of Children LinclNational Center For Research Resources2005–2007
  • Candidate Genes For Susceptibility To BronchitisNational Heart, Lung, And Blood Institute2004–2007
  • Evaluation Of Normals/ Bronchopulmonary Lung Lavage/ Bronchial Brushing EtcNational Center For Research Resources2004–2007
  • Evaluation Of Airways Of Individuals With Lung DiseaseNational Center For Research Resources2004–2007
  • Manipulation Of VEGF Splicing In Angiogenic Gene TherapyNational Heart, Lung, And Blood Institute2002–2006
  • Project #6National Heart, Lung, And Blood Institute2005
  • Weill Cornell Program Of Excellence In Gene TherapyNational Heart, Lung, And Blood Institute2000–2005
  • Anti-Y. Pestis Vaccination And Passive ProtectionNational Institute Of Allergy And Infectious Diseases2003
  • Gene Transfer To Progenitor And Differentiated CellsNational Heart, Lung, And Blood Institute1998–2003
  • SHH Induction Of Post-Natal Hair Follicle/Hair GrowthNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2002
  • T Cell Independent Antipseudomonas Vaccine DevelopmentNational Heart, Lung, And Blood Institute2000–2002
  • Unidirectional Trafficking Of Adenovirus VectorsNational Heart, Lung, And Blood Institute1999–2002
  • Immune Response To Adenovirus Type 5 Gene Transfer VectorNational Center For Research Resources1999–2002
  • Repeat Admin Of Replication Deficient Adenovirus Vector In Cystic FibrosiNational Center For Research Resources1997–2002
  • Evaluation Of The Airways Of Normal Individuals With Bronchopulmonary LavageNational Center For Research Resources1997–2002
  • Pegt Coordinating And Data Core At Weill CornellNational Heart, Lung, And Blood Institute2001
  • VEGF Vector To Ischemic Myocardium W/Diffuse Coronary DiseaseNational Center For Research Resources2000–2001
  • Direct Administrationof Adgvvegf121.10 W/Vegf121cdna To Isch MyocaradiumNational Center For Research Resources1999–2001
  • Direct Admin /Adenoviridae Vector W/Vegf121/ CDNA To Lower Ischemic LimbNational Center For Research Resources1999–2001
  • Regional Angiogenesis Induced By In Vivo Gene TherapyNational Heart, Lung, And Blood Institute1998–2001
  • Evaluation Of Airways Of Normal IndividualsNational Center For Research Resources1998–2001
  • Regional Induction Of Angiogenesis By In Vivo Gene TransferNational Heart, Lung, And Blood Institute1997–2001
  • Gene Transfer To Progenitor And Differentiated CellsNational Heart, Lung, And Blood Institute1997–2001
  • Gene Transfer To Alveolar MacrophagesNational Heart, Lung, And Blood Institute1997–2001
  • Core--Pilot ProjectsNational Heart, Lung, And Blood Institute1997–2001
  • Core--Molecular Biology/Gene TransferNational Heart, Lung, And Blood Institute1997–2001
  • Admin. Of Different Serotypes Of AD Vectors W/Human Thrombopoietin CDNANational Center For Research Resources1999–2000
  • Phase 1 Study/ Direct Admin. Adenovirus Vector/ E Coli Cytosine Deaminase GeneNational Center For Research Resources1997–2000
  • Administration Of Normal CDNA Adenovirus Vector In Cystic FibrosisNational Center For Research Resources1996–2000
  • Alveolar Macrophage Host DefensesNational Heart, Lung, And Blood Institute1997–1999
  • Immune Responses To Intradermal Administration Of An Adenovirus Type 5 GeneNational Center For Research Resources1997–1999
  • Immune Responses To Intradermal Admininistration Of An Adenovirus Type 5 GeneNational Center For Research Resources1997–1999
  • Tumor Immunity VIA Dendritic Cell Genetic AlterationNational Cancer Institute1997–1999
  • Gene Transfer To Alveolar MacrophagesNational Heart, Lung, And Blood Institute1998
  • Core--Pilot ProjectsNational Heart, Lung, And Blood Institute1998
  • Direct Admin REP Defic Adgvvegf121.10 W/Vegf121cdna To Isch MyocaradiumNational Center For Research Resources1998
  • Repet Admin Of Various Serotypes Of Replication Deficient Adenovirus VectorsNational Center For Research Resources1997
  • Direct Admin Of A Replication Deficient Adenovirus Vector In Colorectal Carcin.National Center For Research Resources1997
  • Biologic Materials For Studies Of Tumor Immunity VIA Dendritic CellNational Center For Research Resources1997
  • Adenovirus Vector Transfer Of Gp75 Gene For Treatment Of Metastatic MelanomaNational Center For Research Resources1997
  • (NORMALS) Biologic Materials For Studies Of Tumor Immunity VIA Dendritic CellsNational Center For Research Resources1997
  • Biologic And CT Assessment Of Colon Cancer Gene TherapyNational Cancer Institute1997
  • Efficacy And Safety Of In Vivo Transfer Of The CFTR CDNA TE Airway EpitheliumNational Heart, Lung, And Blood Institute1996–1997
  • Core--Tissue Culture And Adenovirus Vector ProductionNational Heart, Lung, And Blood Institute1996–1997
  • Phase I Cystic Fibrosis Safety/Toxicity/Efficacy Study Of Adenovirus VectorNational Center For Research Resources1996–1997
  • Etiology And Pathogenesis Of Chronic Lung DiseaseNational Center For Research Resources1996–1997
  • Repeat Administration Of Replication Deficient Adenovirus Vector In CFNational Center For Research Resources1996
  • Evaluation Of Airways Of Normal Individuals With Bronchopulmonary LavageNational Center For Research Resources1996
  • Gene Therapy For The Respiratory Mechanisms Of Cystic Fibrosis--Safety And EffNational Center For Research Resources1995
  • Evaluation Of The Airways Of Normal Individuals With Segmental Bronchopul LungvNational Center For Research Resources1995
  • Aerosolization Of Human Alpha 1-Antitrypsin To Individuals With Cystic FibrosisNational Center For Research Resources1995

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    MagnaCare PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment